---
title: MDTB Cell Manufacturing
date: 2023-12-06T09:53:13Z
modified: 2026-08-11T11:04:46Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/mdtb-cell-manufacturing/"
type: portfolio
status: publish
excerpt: ""
wpid: 111183
language:
  - English
post_translations:
  - pll_657043e3f3ba0
branchen22:
  - Immunology
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-11T11:04:46Z
tags:
  - English
  - pll_657043e3f3ba0
  - Immunology
  - Pharmaceuticals
---

## Beschreibungstext

MDTB stands for drugs, which are based on the immunomodulating drug substance Desacell®.
Desacell® is an advanced drug platform based on MSC (Mesenchymal Stromal Cells) and addresses many inflammatory-associated diseases for which there are currently no satisfactory therapies and which lead to high mortality or poor quality of life. Examples include septic shock, acute GvHD and the lung disease BPD.
The mission of MDTB Cell Manufacturing GmbH is the industrial-pharmaceutical production of MSC-based drugs in Germany as clinically well manageable Advanced Therapy Medical Products (off-the-shelf/ready-to-use) to significantly improve the health of affected patients. The manufacturing costs and the progress made in scaling up should also enable application in large patient groups.
Desacell® is currently being tested internationally in several clinical studies.

## Unternehmenswebsite

https://mdtbcells.com/

## Adresse

MDTB Cell Manufacturing GmbH
Tatzberg 47
01307 Dresden